Bendamustin in combination with Fludarabin for the treatment of refractory or relapsed low-grade lymphoma - A multicenter phase I/II trial of the East German study group for hematology and oncology (OSHO).

被引：0
|
作者：
Koenigsmann, MP [1 ]
Knauf, WU [1 ]
Herold, M [1 ]
Franke, A [1 ]
机构：
[1] Otto Von Guericke Univ, Magdeburg, Germany
来源：
BLOOD | 2001年 / 98卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2543
引用
收藏
页码：607A / 607A
页数：1
相关论文
共 50 条
  • [31] Phase I study of the combination of irinotecan hydrochloride, carboplatin, and dexamethasone for the treatment of relapsed or refractory malignant lymphoma
    Suzumiya, J
    Suzushima, H
    Maeda, K
    Okamura, S
    Utsunomiya, A
    Shibuya, T
    Tamura, K
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2004, 79 (03) : 266 - 270
  • [32] High anti-lymphoma activity of bendamustine/mitoxantrone/rituximab in rituximab pretreated relapsed or refractory indolent lymphomas and mantle cell lymphomas.: A multicenter phase II study of the German Low Grade Lymphoma Study Group (GLSG)
    Weide, Rudolf
    Hess, Georg
    Koeppler, Hubert
    Heymanns, Jochen
    Thomalla, Joerg
    Aldaoud, Ali
    Losem, Christoph
    Schmitz, Stefan
    Haak, Ursula
    Huber, Christoph
    Unterhalt, Michael
    Hiddemann, Wolfgang
    Dreyling, Martin
    LEUKEMIA & LYMPHOMA, 2007, 48 (07) : 1299 - 1306
  • [33] Phase I study of the combination of irinotecan hydrochloride, carboplatin, and dexamethasone for the treatment of relapsed or refractory malignant lymphoma
    Junji Suzumiya
    Hitoshi Suzushima
    Kouichi Maeda
    Seiichi Okamura
    Atae Utsunomiya
    Tunefumi Shibuya
    Kazuo Tamura
    International Journal of Hematology, 2004, 79 : 266 - 270
  • [34] Allogeneic stem cell transplantation for mantle cell lymphoma-update of the prospective trials of the East German Study Group Hematology/Oncology (OSHO#60 and #74)
    Krueger, William H.
    Hirt, Carsten
    Basara, Nadezda
    Sayer, Herbert G.
    Behre, Gerhard
    Fischer, Thomas
    Grobe, Norbert
    Maschmeyer, Georg
    Neumann, Thomas
    Schneidewind, Laila
    Niederwieser, Dietger
    Doelken, Gottfried
    Schmidt, Christian A.
    ANNALS OF HEMATOLOGY, 2021, 100 (06) : 1569 - 1577
  • [35] Anxieties, age and motivation influence physical activity in patients with myeloproliferative neoplasms-a multicenter survey from the East German study group for hematology and oncology (OSHO #97)
    Felser, Sabine
    Rogahn, Julia
    le Coutre, Philipp
    Al-Ali, Haifa Kathrin
    Schulze, Susann
    Muegge, Lars-Olof
    Gruen, Julia
    Geissler, Jan
    Kraze-Kliebhahn, Veronika
    Junghanss, Christian
    FRONTIERS IN ONCOLOGY, 2023, 12
  • [36] Multicenter phase II study of iodine-131 tositumomab for chemotherapy-relapsed/refractory low-grade and transformed low-grade B-cell non-Hodgkin's lymphomas
    Vose, JM
    Wahl, RL
    Saleh, M
    Rohatiner, AZ
    Knox, SJ
    Radford, JA
    Zelenetz, AD
    Tidmarsh, GF
    Stagg, RJ
    Kaminski, MS
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (06) : 1316 - 1323
  • [37] Risk-adapted high-dose therapy including autologous and allogeneic stem cell transplantation for relapsed or aggressive non-Hodgkin's lymphoma - a phase II trial by the OSHO (East German Study Group for Haematology and Oncology)
    Koenigsmann, M.
    Kahl, C.
    Freund, M.
    Basara, N.
    Niederwieser, D.
    Sayer, H.
    Theurich, S.
    Christopeit, M.
    Behre, G.
    Mohren, M.
    Franke, A.
    Reichle, A.
    Ganser, A.
    Metzner, B.
    Uharek, L.
    Balleisen, L.
    Hinke, A.
    Hinke, R.
    Casper, J.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S253 - S253
  • [38] Phase II study of cilengitide in the treatment of refractory or relapsed high-grade gliomas in children: A report from the Children's Oncology Group
    MacDonald, Tobey J.
    Vezina, Gilbert
    Stewart, Clinton F.
    Turner, David
    Pierson, Christopher R.
    Chen, Lu
    Pollack, Ian F.
    Gajjar, Amar
    Kieran, Mark W.
    NEURO-ONCOLOGY, 2013, 15 (10) : 1438 - 1444
  • [39] First interim analysis of the Multiple Myeloma Registry of the East German Study Group Hematology / Oncology (OSHO): real world data on treatment in multiple myeloma patients
    Kragl, B.
    Prange-Krex, G.
    Schmidt-Hieber, M.
    Ponisch, W.
    Schmalenberg, H.
    Mugge, L. -O
    Gerhardt, A.
    Scholz, C. W.
    Krammer-Steiner, B.
    Guenther, A.
    Schwarzer, A.
    Kaempfe, D.
    Ligeti, K.
    Trieglaff, U.
    Kahl, C.
    Pfannes, R.
    Leithaeuser, M.
    Blau, I
    Schulze, S.
    Langenkamp, U.
    Junghanss, C.
    Bottcher, S.
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 179 - 179
  • [40] A Phase 2, Open-Label, Multicenter Study of Tazemetostat in Combination with Rituximab for the Treatment of Relapsed or Refractory Follicular Lymphoma
    Patel, Krish
    Bailey, Neil
    Pagel, John M.
    BLOOD, 2020, 136
12345